OncologyPancreatic Neoplasms

Pancreatic Cancer Inflection Point: KRAS Moves, Immunotherapy Catches Up

The most resistant cancer is finally responding, and the pipeline is accelerating

SR-2026-011

EditorMara Voss

CopywritersEditorial Team

Coming Soon

Pancreatic Cancer Inflection Point: KRAS Moves, Immunotherapy Catches Up

The most resistant cancer is finally responding, and the pipeline is accelerating

Why We Are Covering This

RASolute-302 at ASCO 2026 is the most significant pancreatic cancer survival dataset in a decade, nearly doubling median overall survival in KRAS-mutated disease. A second KRAS inhibitor is now entering pivotal trials.

What to Expect

You will understand the clinical profile of each KRAS mutation target in PDAC, how biomarker testing changes patient selection today, and which combination strategies with immunotherapy show the most credible early signals.

Be first when this report publishes

The Life Science Feed briefing covers every major trial readout, approval, and pipeline shift, weekly.

Get the briefing first

thelifesciencefeed.com · Special Report

SR-2026-01107/26

Solid Tumors

Bowhead Whale Longevity Genes Offer Clues for Cancer, Aging

Insights from the bowhead whale's exceptional lifespan and cancer resistance point to novel genetic pathways for human anti-aging and oncology research.

Prostatic Neoplasms

Prostate Care: Balancing Immediate Relief with Long-Term Retreatment

Managing benign prostatic hyperplasia requires weighing rapid symptom improvement against the need for future interventions. Clinicians must consider patient preference and disease progression.

Breast Neoplasms

Genetic Test Identifies Breast Cancer Patients Who May Avoid Chemotherapy

A genetic test can identify patients with early-stage, hormone receptor-positive, HER2-negative breast cancer who may safely forgo adjuvant chemotherapy.

Breast Neoplasms

Giredestrant Improves Breast Cancer Survival Regardless of Menopause

Giredestrant, an oral selective estrogen receptor degrader (SERD), demonstrated improved invasive disease-free survival in early breast cancer.

Pancreatic Cancer Inflection Point: KRAS Moves, Immunotherapy Catches Up

Pancreatic Cancer Inflection Point: KRAS Moves, Immunotherapy Catches Up

Be first when this report publishes

Related Articles